Yuan M, Hoyek S, Kim L, Chaaya C, Patel N
J Vitreoretin Dis. 2024; :24741264241297684.
PMID: 39544710
PMC: 11558646.
DOI: 10.1177/24741264241297684.
Iyer S, Radhakrishnan N, Roohipourmoallai R, Guerin C, Maylath J, Garson N
Am Heart J Plus. 2024; 29:100270.
PMID: 38510674
PMC: 10945896.
DOI: 10.1016/j.ahjo.2023.100270.
Duong R, Cai X, Ambati N, Shildkrot Y
J Vitreoretin Dis. 2023; 7(4):281-289.
PMID: 37927313
PMC: 10621701.
DOI: 10.1177/24741264231169145.
Pehlivanoglu S, Bektasoglu D, Ozcaliskan S, Alagoz C, Erdogan G, Artunay O
Beyoglu Eye J. 2023; 8(3):184-192.
PMID: 37766768
PMC: 10521131.
DOI: 10.14744/bej.2023.26986.
Crispin M, Gerhart J, Heffer A, Martin M, Abdalla F, Bravo-Nuevo A
Invest Ophthalmol Vis Sci. 2023; 64(2):1.
PMID: 36723927
PMC: 9904330.
DOI: 10.1167/iovs.64.2.1.
Safety and Efficacy of Hypersonic Vitrectomy for Retinal Reattachment Surgery in Proliferative Vitreoretinopathies.
Deuchler S, Scholtz J, Knoch T, Seitz B, Koch F
Clin Ophthalmol. 2022; 16:3711-3720.
PMID: 36389636
PMC: 9664922.
DOI: 10.2147/OPTH.S386014.
Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy.
Yan A, Zhang Y, Wang X, Cui Y, Tan W
Bioengineered. 2022; 13(5):13293-13299.
PMID: 35635032
PMC: 9275983.
DOI: 10.1080/21655979.2022.2080367.
Discordance in Retinal and Choroidal Vascular Densities in Patients with Type 2 Diabetes Mellitus on Optical Coherence Tomography Angiography.
Ra H, Kang N, Song J, Lee J, Kim I, Baek J
J Ophthalmol. 2021; 2021:8871602.
PMID: 33747557
PMC: 7945675.
DOI: 10.1155/2021/8871602.
Cytokines associated with hemorrhage in proliferative diabetic retinopathy.
Ra H, Lee A, Lee J, Kim I, Baek J
Int Ophthalmol. 2021; 41(5):1845-1853.
PMID: 33609201
DOI: 10.1007/s10792-021-01746-9.
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.
Lyon H, Shome A, Rupenthal I, Green C, Mugisho O
Int J Mol Sci. 2021; 22(1).
PMID: 33396676
PMC: 7794685.
DOI: 10.3390/ijms22010298.
Effect of Intrasilicone Bevacizumab Injection in Diabetic Tractional Retinal Detachment Surgery: A Retrospective Case-Control Study.
Baek S, Lee M, Lee Y
J Clin Med. 2020; 9(10).
PMID: 32993113
PMC: 7601065.
DOI: 10.3390/jcm9103114.
Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway.
Chen X, Yang W, Deng X, Ye S, Xiao W
Mol Vis. 2020; 26:517-529.
PMID: 32818015
PMC: 7406861.
Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates.
Lin H, Yang C, Chen S, Hsieh Y
PLoS One. 2020; 15(7):e0236867.
PMID: 32735583
PMC: 7394381.
DOI: 10.1371/journal.pone.0236867.
Retinal blood oxygen saturation and vascular endothelial growth factor-A in early diabetic retinopathy: A protocol for systematic review and meta-analysis.
Qiu X, Wang X, Hong P, Liu M, Wen Q, Chen Q
Medicine (Baltimore). 2020; 99(24):e20562.
PMID: 32541481
PMC: 7302675.
DOI: 10.1097/MD.0000000000020562.
Reviving the lost art of scleral buckling surgery for rhegmatogenous retinal detachment: evaluation of risk factors of detachments, poor physiological outcomes, and perspective from a developing country.
Singh S, Khatri A, Byanju R, Kharel M, Joshi K, Khadka Thapa S
Ther Adv Ophthalmol. 2019; 11:2515841419838662.
PMID: 31001604
PMC: 6454650.
DOI: 10.1177/2515841419838662.
Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy.
Cui J, Chen H, Lu H, Dong F, Wei D, Jiao Y
J Ophthalmol. 2018; 2018:4927259.
PMID: 30046459
PMC: 6036808.
DOI: 10.1155/2018/4927259.
Novel NADPH oxidase inhibitor VAS2870 suppresses TGF‑β‑dependent epithelial‑to‑mesenchymal transition in retinal pigment epithelial cells.
Yang J, Li J, Wang Q, Xing Y, Tan Z, Kang Q
Int J Mol Med. 2018; 42(1):123-130.
PMID: 29620174
PMC: 5979836.
DOI: 10.3892/ijmm.2018.3612.
Key Factors to Improve the Outcome of Retinal Reattachment Surgery in Proliferative Vitreoretinopathy and Proliferative Diabetic Retinopathy.
Deuchler S, Ackermann H, Singh P, Kohnen T, Wagner C, Koch F
J Ophthalmol. 2017; 2017:2323897.
PMID: 28770107
PMC: 5523461.
DOI: 10.1155/2017/2323897.
ASSESSMENT OF RETINAL BLOOD FLOW IN DIABETIC RETINOPATHY USING DOPPLER FOURIER-DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
Srinivas S, Tan O, Nittala M, Wu J, Fawzi A, Huang D
Retina. 2017; 37(11):2001-2007.
PMID: 28098726
PMC: 6581777.
DOI: 10.1097/IAE.0000000000001479.
Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
Telander D, Yu A, Forward K, Morales S, Morse L, Park S
Invest Ophthalmol Vis Sci. 2016; 57(7):3112-7.
PMID: 27294805
PMC: 4913806.
DOI: 10.1167/iovs.15-17791.